Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Bilateral Acute Retinal Necrosis: Clinical Features and Outcomes in a Multicenter Study.

Miserocchi E, Iuliano L, Fogliato G, Modorati G, Couto C, Schlaen A, Hurtado E, Llorenç V, Adan A, Bandello F.

Ocul Immunol Inflamm. 2018 Jul 30:1-9. doi: 10.1080/09273948.2018.1501494. [Epub ahead of print]

PMID:
30059636
2.

Ocular disorders in multiple myeloma patients: cross-sectional study of prevalence and association with treatment.

Pennisi M, Berchicci L, Miserocchi E, Mussetti A, Cacioppo V, David A, Scialdone A, Lorusso I, Modorati G, Corradini P, Montefusco V.

Leuk Lymphoma. 2018 Jul 22:1-6. doi: 10.1080/10428194.2018.1480770. [Epub ahead of print]

PMID:
30033858
3.

Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement.

Olivieri I, Accorinti M, Abicca I, Bisceglia P, Cimino L, Latanza L, Leccese P, Lubrano E, Marchesoni A, Miserocchi E, Neri P, Salvarani C, Scarpa R, D'Angelo S; CORE Study Group.

Rheumatol Int. 2018 Jun 30. doi: 10.1007/s00296-018-4094-1. [Epub ahead of print]

PMID:
29961101
4.

Leopard-Spot Subretinal Deposits in Central Serous Chorioretinopathy.

Marchese A, Miserocchi E, Modorati G, Querques G, Bandello F.

Retina. 2018 Jul;38(7):e53-e54. doi: 10.1097/IAE.0000000000002204. No abstract available.

PMID:
29697592
5.

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.

Cecchin V, Zannin ME, Ferrari D, Pontikaki I, Miserocchi E, Paroli MP, Bracaglia C, Marafon DP, Pastore S, Parentin F, Simonini G, De Libero C, Falcini F, Petaccia A, Filocamo G, De Marco R, La Torre F, Guerriero S, Martino S, Comacchio F, Muratore V, Martini G, Vittadello F, Zulian F.

J Rheumatol. 2018 Aug;45(8):1167-1172. doi: 10.3899/jrheum.171006. Epub 2018 Apr 15.

6.

Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center.

Berchicci L, Rabiolo A, Marchese A, Iuliano L, Gigliotti C, Miserocchi E, Bandello F, Modorati G.

Ocul Surf. 2018 Jul;16(3):314-321. doi: 10.1016/j.jtos.2018.04.001. Epub 2018 Apr 4.

PMID:
29625303
7.

Varicell Zoster Virus-Associated Uveitis.

Cunningham ET Jr, Miserocchi E, Tugal-Tutkun I, Zierhut M.

Ocul Immunol Inflamm. 2018;26(2):167-170. doi: 10.1080/09273948.2018.1444120. No abstract available.

PMID:
29498922
8.

Swept-source optical coherence tomography angiography in serpiginous choroiditis.

Montorio D, Giuffrè C, Miserocchi E, Modorati G, Sacconi R, Mercuri S, Querques L, Querques G, Bandello F.

Br J Ophthalmol. 2018 Jul;102(7):991-995. doi: 10.1136/bjophthalmol-2017-310989. Epub 2017 Oct 5.

PMID:
28982952
9.

Predictors of radio-induced visual impairment after radiosurgery for uveal melanoma.

Gigliotti CR, Modorati G, Di Nicola M, Fiorino C, Perna LA, Miserocchi E, Franzin A, Picozzi P, Bolognesi A, Mortini P, Del Vecchio A, Calandrino R.

Br J Ophthalmol. 2018 Jun;102(6):833-839. doi: 10.1136/bjophthalmol-2017-310801. Epub 2017 Sep 13.

PMID:
28903963
10.

Association Between Visual Function Response and Reduction of Inflammation in Noninfectious Uveitis of the Posterior Segment.

Lescrauwaet B, Miserocchi E, Thurau S, Bodaghi B, Duchateau L, Verstraeten T, Srivastava S.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3555-3562. doi: 10.1167/iovs.17-22049.

PMID:
28715589
11.

SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN ENDOGENOUS CANDIDA ENDOPHTHALMITIS AND THEIR CLINICAL RELEVANCE.

Invernizzi A, Symes R, Miserocchi E, Cozzi M, Cereda M, Fogliato G, Staurenghi G, Cimino L, McCluskey P.

Retina. 2018 May;38(5):1011-1018. doi: 10.1097/IAE.0000000000001630.

PMID:
28492430
12.

Hemorrhagic occlusive retinal vasculitis after inadvertent intraocular perforation with gentamycin injection.

Querques L, Miserocchi E, Modorati G, Querques G, Bandello F.

Eur J Ophthalmol. 2017 Mar 10;27(2):e50-e53. doi: 10.5301/ejo.5000874.

PMID:
28233891
13.

CENTRAL SEROUS CHORIORETINOPATHYLIKE MIMICKING MULTIFOCAL VITELLIFORM MACULAR DYSTROPHY: AN OCULAR SIDE EFFECT OF MITOGEN/EXTRACELLULAR SIGNAL-REGULATED KINASE INHIBITORS.

Giuffrè C, Miserocchi E, Modorati G, Carnevali A, Marchese A, Querques L, Querques G, Bandello F.

Retin Cases Brief Rep. 2018 Summer;12(3):172-176. doi: 10.1097/ICB.0000000000000491.

PMID:
27902541
14.

Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.

Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.

J Rheumatol. 2016 Nov;43(11):2068-2073. Epub 2016 Sep 15.

PMID:
27633826
15.

Diagnostic and Therapeutic Challenges.

Corvi F, Lattanzio R, Miserocchi E, Querques L, Bandello F, Querques G, Croft DE, Wykoff CC.

Retina. 2016 Nov;36(11):2239-2245. No abstract available.

PMID:
27322945
16.

Dexamethasone intravitreal implant in serpiginous choroiditis.

Miserocchi E, Berchicci L, Iuliano L, Modorati G, Bandello F.

Br J Ophthalmol. 2017 Mar;101(3):327-332. doi: 10.1136/bjophthalmol-2015-307820. Epub 2016 Jun 2.

PMID:
27256717
17.

Bilateral Endogenous Endophthalmitis Caused by Candida albicans After Breast Implant Surgery.

Querques G, Modorati G, Miserocchi E, Baruffaldi Preis F, Bandello F.

JAMA Ophthalmol. 2016 Apr;134(4):467-9. doi: 10.1001/jamaophthalmol.2016.0015. No abstract available.

PMID:
26985776
18.

Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis.

Kolomeyer AM, Tu Y, Miserocchi E, Ranjan M, Davidow A, Chu DS.

Ocul Immunol Inflamm. 2016 Aug;24(4):377-85. doi: 10.3109/09273948.2015.1125509. Epub 2016 Feb 22.

PMID:
26902465
19.

Intravitreal aflibercept for choroidal neovascularization in ocular sarcoidosis.

Querques L, Querques G, Miserocchi E, Modorati G, Bandello F.

Eur J Ophthalmol. 2016 Aug 4;26(5):e124-7. doi: 10.5301/ejo.5000759.

PMID:
26868005
20.

Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis.

Amin RM, Miserocchi E, Thorne JE, Hornbeak D, Jabs DA, Zierhut M.

Ocul Immunol Inflamm. 2016;24(1):81-90. doi: 10.3109/09273948.2015.1077976. Epub 2015 Dec 11. Review.

PMID:
26652068
21.

Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis.

Miserocchi E, Modorati G, Berchicci L, Pontikaki I, Meroni P, Gerloni V.

Br J Ophthalmol. 2016 Jun;100(6):782-6. doi: 10.1136/bjophthalmol-2015-306790. Epub 2015 Sep 22.

PMID:
26396026
22.

New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient.

Miserocchi E, Cimminiello C, Mazzola M, Russo V, Modorati GM.

Can J Ophthalmol. 2015 Feb;50(1):e2-4. doi: 10.1016/j.jcjo.2014.10.010. No abstract available.

PMID:
25677296
23.

Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis.

Tappeiner C, Miserocchi E, Bodaghi B, Kotaniemi K, Mackensen F, Gerloni V, Quartier P, Lutz T, Heiligenhaus A.

J Rheumatol. 2015 Apr;42(4):706-11. doi: 10.3899/jrheum.140410. Epub 2015 Feb 1.

PMID:
25641892
24.

Tear osmolarity in ocular graft-versus-host disease.

Berchicci L, Iuliano L, Miserocchi E, Bandello F, Modorati G.

Cornea. 2014 Dec;33(12):1252-6. doi: 10.1097/ICO.0000000000000283.

PMID:
25343699
25.

Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study.

Ingegnoli F, Gualtierotti R, Pierro L, Del Turco C, Miserocchi E, Schioppo T, Meroni PL; ACUTE study group; ACUTE study group.

Microvasc Res. 2015 Jan;97:31-6. doi: 10.1016/j.mvr.2014.08.008. Epub 2014 Sep 26.

PMID:
25262916
26.

Sarcoid uveitis.

Cunningham ET Jr, Lowder CY, Miserocchi E, Thorne JE, Zierhut M.

Ocul Immunol Inflamm. 2014 Aug;22(4):253-6. doi: 10.3109/09273948.2014.941235. Review. No abstract available.

PMID:
25014115
27.

Tear film osmolarity in ocular mucous membrane pemphigoid.

Miserocchi E, Iuliano L, Berchicci L, Bandello F, Modorati G.

Cornea. 2014 Jul;33(7):668-72. doi: 10.1097/ICO.0000000000000148.

PMID:
24858022
28.

Clinical features of ocular herpetic infection in an italian referral center.

Miserocchi E, Fogliato G, Bianchi I, Bandello F, Modorati G.

Cornea. 2014 Jun;33(6):565-70. doi: 10.1097/ICO.0000000000000129.

PMID:
24763121
29.

Angiographic evidence of retinal artery transient occlusion in paracentral acute middle maculopathy.

Querques G, La Spina C, Miserocchi E, Gagliardi M, Corvi F, Bandello F.

Retina. 2014 Oct;34(10):2158-60. doi: 10.1097/IAE.0000000000000140. No abstract available.

PMID:
24732698
30.

HLA-A29-Positive Uveitis: Birdshot Chorioretinopathy, What Else?

Zucchiatti I, Miserocchi E, Sacconi R, Bandello F, Modorati G.

Case Rep Ophthalmol. 2013 Dec 7;4(3):287-93. doi: 10.1159/000357276. eCollection 2013 Sep.

31.

Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center.

Berchicci L, Miserocchi E, Di Nicola M, La Spina C, Bandello F, Modorati G.

Eur J Ophthalmol. 2014 May-Jun;24(3):293-8. doi: 10.5301/ejo.5000394. Epub 2013 Nov 12.

PMID:
24242216
32.

Long-term treatment with golimumab for severe uveitis.

Miserocchi E, Modorati G, Pontikaki I, Meroni PL, Gerloni V.

Ocul Immunol Inflamm. 2014 Apr;22(2):90-5. doi: 10.3109/09273948.2013.844265. Epub 2013 Oct 21. Erratum in: Ocul Immunol Inflamm. 2015 Jun;23(3):266.

PMID:
24143896
33.

Atypical presentation of a pigmented oncocytoma of the caruncle: a case report.

Di Nicola M, Miserocchi E, Rizzo N, Grantoza CL, Bandello F, Modorati G.

Case Rep Ophthalmol. 2013 Jun 6;4(2):16-9. doi: 10.1159/000353222. Print 2013 May.

34.

Review on the worldwide epidemiology of uveitis.

Miserocchi E, Fogliato G, Modorati G, Bandello F.

Eur J Ophthalmol. 2013 Sep-Oct;23(5):705-17. doi: 10.5301/ejo.5000278. Epub 2013 May 3. Review.

PMID:
23661536
35.

Golimumab treatment for complicated uveitis.

Miserocchi E, Modorati G, Pontikaki I, Meroni P, Gerloni V.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):320-1. Epub 2013 Jan 18. No abstract available. Erratum in: Clin Exp Rheumatol. 2014 Sep-Oct;32(5):764.

PMID:
23331715
36.

Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry.

Zannin ME, Birolo C, Gerloni VM, Miserocchi E, Pontikaki I, Paroli MP, Bracaglia C, Shardlow A, Parentin F, Cimaz R, Simonini G, Falcini F, Corona F, Viola S, De Marco R, Breda L, La Torre F, Vittadello F, Martini G, Zulian F.

J Rheumatol. 2013 Jan;40(1):74-9. doi: 10.3899/jrheum.120583. Epub 2012 Nov 1. Erratum in: J Rheumatol. 2013 Jan;40(1):106.

PMID:
23118110
37.

Dexamethasone intravitreal implant: an effective adjunctive treatment for recalcitrant noninfectious uveitis.

Miserocchi E, Modorati G, Pastore MR, Bandello F.

Ophthalmologica. 2012;228(4):229-33. doi: 10.1159/000343060. Epub 2012 Oct 3.

38.

Birdshot retinochoroidopathy masquerading as intraocular lymphoma.

Miserocchi E, Modorati G, De Benedetto U, Colucci A, Bandello F.

Ocul Immunol Inflamm. 2012 Aug;20(4):306-8. doi: 10.3109/09273948.2012.689074. Epub 2012 May 17.

PMID:
22594959
39.

Intravitreal injection therapy in the treatment of noninfectious uveitis.

Modorati G, Miserocchi E.

Dev Ophthalmol. 2012;51:110-21. doi: 10.1159/000336471. Epub 2012 Apr 17. Review.

PMID:
22517209
40.

Rituximab for noninfectious uveitis.

Miserocchi E, Modorati G.

Dev Ophthalmol. 2012;51:98-109. doi: 10.1159/000336188. Epub 2012 Apr 17. Review.

PMID:
22517208
41.

Clinical application of an in-house ELISPOT assay in patients with suspicious tuberculous uveitis and no signs of active tuberculosis.

Modorati G, Berchicci L, Miserocchi E, Scarpellini P, Mantegani P, Bandello F, Ortis C.

Eur J Ophthalmol. 2012 Sep-Oct;22(5):808-13. doi: 10.5301/ejo.5000121.

PMID:
22344468
42.

Increased stromal cell-derived factor-1 concentration levels in aqueous from patients with uveal melanoma.

Zerbini G, Colucci A, Maestroni A, Miserocchi E, Bandello F, Modorati G.

Melanoma Res. 2012 Feb;22(1):98-9. doi: 10.1097/CMR.0b013e32834e1f50. No abstract available.

PMID:
22228277
43.

Serous Retinal Detachments Complicating Interferon-α and Ribavirin Treatment in Patients with Hepatitis C.

Modorati G, Matteo DF, Miserocchi E, Colucci A, Bandello F.

Case Rep Ophthalmol. 2011 Jan;2(1):105-10. doi: 10.1159/000326747. Epub 2011 Mar 12.

44.

Understanding uveitis: the impact of research on visual outcomes.

de Smet MD, Taylor SR, Bodaghi B, Miserocchi E, Murray PI, Pleyer U, Zierhut M, Barisani-Asenbauer T, LeHoang P, Lightman S.

Prog Retin Eye Res. 2011 Nov;30(6):452-70. doi: 10.1016/j.preteyeres.2011.06.005. Epub 2011 Jul 22. Review.

PMID:
21807112
45.

Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.

Miserocchi E, Pontikaki I, Modorati G, Gattinara M, Meroni PL, Gerloni V.

Autoimmun Rev. 2011 Nov;11(1):35-9. doi: 10.1016/j.autrev.2011.07.001. Epub 2011 Jul 13. Review.

46.

Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab).

Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K.

Rheumatology (Oxford). 2011 Aug;50(8):1390-4. doi: 10.1093/rheumatology/ker107. Epub 2011 Mar 4.

PMID:
21378109
47.

Visual outcome in ocular sarcoidosis: retrospective evaluation of risk factors.

Miserocchi E, Modorati G, Di Matteo F, Galli L, Rama P, Bandello F.

Eur J Ophthalmol. 2011 Nov-Dec;21(6):802-10. doi: 10.5301/EJO.2011.6417.

PMID:
21374555
48.

Rituximab for uveitis.

Miserocchi E, Pontikaki I, Modorati G, Bandello F, Meroni PL, Gerloni V.

Ophthalmology. 2011 Jan;118(1):223-4. doi: 10.1016/j.ophtha.2010.07.031. No abstract available.

PMID:
21199719
49.

Quality of life in patients with uveitis on chronic systemic immunosuppressive treatment.

Miserocchi E, Modorati G, Mosconi P, Colucci A, Bandello F.

Ocul Immunol Inflamm. 2010 Aug;18(4):297-304. doi: 10.3109/09273941003637510.

PMID:
20482406
50.

Atypical toxoplasmosis masquerading late occurrence of typical findings.

Miserocchi E, Modorati G, Rama P.

Eur J Ophthalmol. 2009 Nov-Dec;19(6):1091-3.

PMID:
19882557

Supplemental Content

Loading ...
Support Center